Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study |
| |
| Authors: | GC Farrell BR Bacon RD Goldin |
| |
| Affiliation: | Liver Diseases Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892, USA. daryll@bdg10.niddk,nih.gov |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
